Related Experiment Video
Updated: Sep 20, 2026

Electrophoretic Analysis of Replication Through Structure-Prone DNA Repeats Within the SV40-Based Human Episome
Published on: September 13, 2024
Simian virus 40 and its association with human lymphomas
Regis A Vilchez1, Janet S Butel
1Department of Medicine, Baylor College of Medicine, Mail Stop BCM-385, One Baylor Plaza, Houston, TX 77030, USA.
Abstract:
Simian virus 40 (SV40) is a potent DNA tumor virus that is known to induce cancer in laboratory animals. The neoplasias induced by SV40 in animal models are brain cancers, mesothelioma, bone cancers, and systemic lymphomas. SV40 oncogenesis is mediated primarily by the viral large tumor antigen, which inactivates the tumor suppressor proteins p53 and pRb family members. Evidence indicates that SV40 is an emergent human pathogen and that a significant excess risk of SV40 is associated with primary human brain cancers, malignant mesothelioma, bone cancers, and non-Hodgkin's lymphoma. Therefore, the major types of tumors induced by SV40 in laboratory animals are the same as those human malignancies found to contain SV40 markers. Experimental and clinical data indicate that SV40 may be functionally important in the development of some of those malignancies. Recently, the Institute of Medicine of the National Academies concluded that SV40 infections could lead to cancer in humans under natural conditions (based on moderate strength biologic evidence). This review examines the data implicating SV40 in the pathogenesis of human lymphomas and discusses future directions to define the causative role for SV40 in these malignancies.
Insights
Simian virus 40 (SV40) is a DNA tumor virus linked to various cancers in animals and humans. Research suggests SV40 may play a role in human lymphoma development.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Simian virus 40 (SV40) is a DNA tumor virus known to cause cancer in animals.
- SV40 oncogenesis involves the viral large tumor antigen inactivating tumor suppressor proteins.
- SV40 is recognized as an emergent human pathogen.
Purpose of the Study:
- To review evidence implicating SV40 in human lymphoma pathogenesis.
- To discuss future research directions for defining SV40's causative role in malignancies.
Main Methods:
- Review of experimental and clinical data.
- Analysis of studies linking SV40 to human cancers.
- Examination of SV40 markers in human malignancies.
Main Results:
- SV40 induces brain cancers, mesothelioma, bone cancers, and lymphomas in animals.
- SV40 is associated with an increased risk of human brain cancers, mesothelioma, bone cancers, and non-Hodgkin's lymphoma.
- Tumors induced by SV40 in animals share similarities with human malignancies containing SV40 markers.
Conclusions:
- SV40 may be functionally important in the development of certain human malignancies.
- The Institute of Medicine concluded SV40 infections could potentially cause cancer in humans.
- Further research is needed to definitively establish SV40's causative role in human lymphomas.
More Related Videos
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
06:25Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining
Published on: December 23, 2016
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cytomegalovirus Disease
Viral Recombination